Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Ocular rosacea
ADR ID BADD_A11242
ADR Hierarchy
06      Eye disorders
06.04      Ocular infections, irritations and inflammations
06.04.05      Ocular infections, inflammations and associated manifestations
06.04.05.032      Ocular rosacea
23      Skin and subcutaneous tissue disorders
23.02      Skin appendage conditions
23.02.08      Rosaceas
23.02.08.002      Ocular rosacea
Description A cutaneous disorder primarily of convexities of the central part of the FACE, such as FOREHEAD; CHEEK; NOSE; and CHIN. It is characterized by FLUSHING; ERYTHEMA; EDEMA; RHINOPHYMA; papules; and ocular symptoms. It may occur at any age but typically after age 30. There are various subtypes of rosacea: erythematotelangiectatic, papulopustular, phymatous, and ocular (National Rosacea Society's Expert Committee on the Classification and Staging of Rosacea, J Am Acad Dermatol 2002; 46:584-7). | A variant of rosacea. [MeSH]
MedDRA Code 10072139
MeSH ID D012393
ADR Severity Grade (FAERS) Not Available
ADR Severity Grade (CTCAE) Not Available
Synonym
Rosacea conjunctivitis | Ocular rosacea | Rosacea | Acne Rosacea | Phymatous Rosacea | Rosacea, Phymatous | Ocular Rosacea | Rosacea, Ocular | Papulopustular Rosacea | Rosacea, Papulopustular | Erythematotelangiectatic Rosacea | Rosacea, Erythematotelangiectatic | Granulomatous Rosacea | Rosacea, Granulomatous
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01232Ketorolac--
The 1th Page    1    Total 1 Pages